We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Verona Pharma plc is one of them. Verona Pharma plc (NASDAQ:VRNA) is a biopharmaceutical company developing therapies for respiratory diseases. Its lead product, Ohtuvayre (ensifentrine), is a first-in-class inhaled dual inhibitor of PDE3 and PDE4 for maintenance treatment of chronic obstructive pulmonary disease (COPD). Combining bronchodilator and anti-inflammatory effects, Ohtuvayre received FDA approval in June 2 ...